Fluoroquinolone Use andClostridium difficile–associated Diarrhea
Open Access
- 1 June 2003
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (6) , 730-733
- https://doi.org/10.3201/eid0906.020385
Abstract
We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile–associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confidence interval 2.6 to 61.6) was the strongest risk factor for CDAD.Keywords
This publication has 19 references indexed in Scilit:
- Antibiotic-Associated DiarrheaNew England Journal of Medicine, 2002
- Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated DiarrheaInfection Control & Hospital Epidemiology, 2001
- Antibiotics andClostridium difficileNew England Journal of Medicine, 1999
- Clostridium difficile–Associated DiarrheaClinical Infectious Diseases, 1998
- Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrheaThe American Journal of Medicine, 1996
- Clostridium Difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995
- Ciprofloxacin and Clostridium difficile-associated diarrhoeaJournal of Antimicrobial Chemotherapy, 1992
- Ciprofloxacin and pseudomembranous colitisThe Lancet, 1990
- Ciprofloxacin and Clostridium difficile infectionThe Lancet, 1990
- Pseudomembranous colitis associated with ciprofloxacinThe Lancet, 1990